Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.922 | 1.88e-16 | 1.65e-04 | 1.58e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
FTL | 2512 | 2 | -2.396 | 2.922 | 25 | Yes | Yes |
PXN | 5829 | 19 | -2.554 | 3.193 | 206 | Yes | Yes |
PKLR | 5313 | 1 | -2.026 | 2.922 | 46 | Yes | - |
[ MYOC ] | 4653 | 1 | -1.812 | 2.922 | 38 | - | - |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
SRSF3 | 6428 | 73 | -2.992 | 3.538 | 54 | Yes | - |
MVP | 9961 | 16 | -2.846 | 3.193 | 20 | Yes | Yes |
HNRNPU | 3192 | 76 | -2.869 | 3.538 | 139 | Yes | - |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
DDIT3 | 1649 | 60 | -2.825 | 3.504 | 343 | Yes | Yes |
FUBP1 | 8880 | 3 | -2.414 | 2.955 | 23 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
MYOC | 4653 | FUBP1 | 8880 | pp | -- | int.I2D: HPRD; int.HPRD: yeast 2-hybrid |
MYOC | 4653 | PKLR | 5313 | pp | -- | int.I2D: HPRD; int.HPRD: yeast 2-hybrid |
PXN | 5829 | SRSF3 | 6428 | pp | -- | int.I2D: BIND |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
FTL | 2512 | MYOC | 4653 | pp | -- | int.I2D: HPRD; int.HPRD: yeast 2-hybrid |
POU5F1 | 5460 | SRSF3 | 6428 | pp | -- | int.I2D: BioGrid |
PKLR | 5313 | PXN | 5829 | pp | -- | int.I2D: BioGrid |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
DDIT3 | 1649 | PKLR | 5313 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
PXN | 5829 | MVP | 9961 | pp | -- | int.I2D: BIND |
DDIT3 | 1649 | HNRNPU | 3192 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 4.11e-05 | 5.92e-01 | 7.656 | 2 | 2 | 13 |
GO:0044212 | transcription regulatory region DNA binding | 2.39e-04 | 1.00e+00 | 4.549 | 3 | 17 | 168 |
GO:0005654 | nucleoplasm | 7.42e-04 | 1.00e+00 | 2.599 | 5 | 64 | 1082 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0023057 | negative regulation of signaling | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0072376 | protein activation cascade | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0014734 | skeletal muscle hypertrophy | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0051435 | BH4 domain binding | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0038133 | ERBB2-ERBB3 signaling pathway | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0005515 | protein binding | 1.10e-03 | 1.00e+00 | 1.122 | 10 | 198 | 6024 |
GO:0004743 | pyruvate kinase activity | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0008043 | intracellular ferritin complex | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0060242 | contact inhibition | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0001649 | osteoblast differentiation | 2.13e-03 | 1.00e+00 | 4.833 | 2 | 5 | 92 |
GO:0032027 | myosin light chain binding | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0038127 | ERBB signaling pathway | 3.05e-03 | 1.00e+00 | 8.357 | 1 | 1 | 4 |
GO:0042866 | pyruvate biosynthetic process | 3.05e-03 | 1.00e+00 | 8.357 | 1 | 1 | 4 |
GO:0051707 | response to other organism | 3.05e-03 | 1.00e+00 | 8.357 | 1 | 1 | 4 |
GO:0030529 | ribonucleoprotein complex | 3.14e-03 | 1.00e+00 | 4.549 | 2 | 5 | 112 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.38e-03 | 1.00e+00 | 3.231 | 3 | 30 | 419 |
GO:0001714 | endodermal cell fate specification | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 2 | 5 |
GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0051901 | positive regulation of mitochondrial depolarization | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 3 | 6 |
GO:0030955 | potassium ion binding | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 7 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 7 |
GO:0045162 | clustering of voltage-gated sodium channels | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 7 |
GO:0006974 | cellular response to DNA damage stimulus | 5.63e-03 | 1.00e+00 | 4.118 | 2 | 7 | 151 |
GO:0031325 | positive regulation of cellular metabolic process | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 8 |
GO:0001955 | blood vessel maturation | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 8 |
GO:0007172 | signal complex assembly | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 8 |
GO:0060396 | growth hormone receptor signaling pathway | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 8 |
GO:0044822 | poly(A) RNA binding | 6.21e-03 | 1.00e+00 | 2.312 | 4 | 50 | 1056 |
GO:0000398 | mRNA splicing, via spliceosome | 6.61e-03 | 1.00e+00 | 3.999 | 2 | 15 | 164 |
GO:0008199 | ferric iron binding | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 9 |
GO:0031953 | negative regulation of protein autophosphorylation | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 9 |
GO:0006826 | iron ion transport | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 9 |
GO:0051497 | negative regulation of stress fiber assembly | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 9 |
GO:0035413 | positive regulation of catenin import into nucleus | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 2 | 10 |
GO:0010226 | response to lithium ion | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 2 | 10 |
GO:0003714 | transcription corepressor activity | 7.74e-03 | 1.00e+00 | 3.881 | 2 | 11 | 178 |
GO:0035024 | negative regulation of Rho protein signal transduction | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 1 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 3 | 11 |
GO:0017166 | vinculin binding | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 4 | 11 |
GO:0001953 | negative regulation of cell-matrix adhesion | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 2 | 12 |
GO:0022011 | myelination in peripheral nervous system | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 12 |
GO:0071480 | cellular response to gamma radiation | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 13 |
GO:0034614 | cellular response to reactive oxygen species | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 2 | 14 |
GO:0043408 | regulation of MAPK cascade | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 1 | 14 |
GO:0001824 | blastocyst development | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 2 | 15 |
GO:0033268 | node of Ranvier | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 16 |
GO:0043274 | phospholipase binding | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 16 |
GO:0033198 | response to ATP | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 16 |
GO:0010467 | gene expression | 1.24e-02 | 1.00e+00 | 2.556 | 3 | 45 | 669 |
GO:0008380 | RNA splicing | 1.25e-02 | 1.00e+00 | 3.524 | 2 | 22 | 228 |
GO:0051894 | positive regulation of focal adhesion assembly | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 18 |
GO:0006754 | ATP biosynthetic process | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 2 | 18 |
GO:0008134 | transcription factor binding | 1.40e-02 | 1.00e+00 | 3.438 | 2 | 18 | 242 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1.40e-02 | 1.00e+00 | 2.492 | 3 | 39 | 699 |
GO:0032757 | positive regulation of interleukin-8 production | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 1 | 20 |
GO:0048041 | focal adhesion assembly | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 1 | 21 |
GO:0055072 | iron ion homeostasis | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 2 | 21 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 2 | 22 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 4 | 22 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 1.74e-02 | 1.00e+00 | 5.833 | 1 | 3 | 23 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 1.74e-02 | 1.00e+00 | 5.833 | 1 | 1 | 23 |
GO:0001968 | fibronectin binding | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 1 | 25 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.93e-02 | 1.00e+00 | 2.318 | 3 | 41 | 789 |
GO:0035329 | hippo signaling | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 5 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 1 | 26 |
GO:0048754 | branching morphogenesis of an epithelial tube | 2.04e-02 | 1.00e+00 | 5.602 | 1 | 1 | 27 |
GO:0005875 | microtubule associated complex | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 1 | 28 |
GO:0030032 | lamellipodium assembly | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 29 |
GO:0019901 | protein kinase binding | 2.32e-02 | 1.00e+00 | 3.048 | 2 | 18 | 317 |
GO:0005109 | frizzled binding | 2.34e-02 | 1.00e+00 | 5.402 | 1 | 1 | 31 |
GO:0042594 | response to starvation | 2.34e-02 | 1.00e+00 | 5.402 | 1 | 4 | 31 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 2.41e-02 | 1.00e+00 | 5.357 | 1 | 2 | 32 |
GO:0008283 | cell proliferation | 2.48e-02 | 1.00e+00 | 2.999 | 2 | 14 | 328 |
GO:0060348 | bone development | 2.49e-02 | 1.00e+00 | 5.312 | 1 | 2 | 33 |
GO:0030971 | receptor tyrosine kinase binding | 2.49e-02 | 1.00e+00 | 5.312 | 1 | 2 | 33 |
GO:0031018 | endocrine pancreas development | 2.64e-02 | 1.00e+00 | 5.227 | 1 | 2 | 35 |
GO:0005791 | rough endoplasmic reticulum | 2.64e-02 | 1.00e+00 | 5.227 | 1 | 1 | 35 |
GO:0003723 | RNA binding | 2.68e-02 | 1.00e+00 | 2.939 | 2 | 18 | 342 |
GO:0034446 | substrate adhesion-dependent cell spreading | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 2 | 36 |
GO:0043565 | sequence-specific DNA binding | 2.74e-02 | 1.00e+00 | 2.922 | 2 | 11 | 346 |
GO:0005829 | cytosol | 2.85e-02 | 1.00e+00 | 1.393 | 5 | 86 | 2496 |
GO:0006096 | glycolytic process | 2.86e-02 | 1.00e+00 | 5.109 | 1 | 3 | 38 |
GO:0051496 | positive regulation of stress fiber assembly | 2.86e-02 | 1.00e+00 | 5.109 | 1 | 4 | 38 |
GO:0005634 | nucleus | 2.89e-02 | 1.00e+00 | 1.010 | 7 | 159 | 4559 |
GO:0009408 | response to heat | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 6 | 40 |
GO:0035019 | somatic stem cell maintenance | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 6 | 40 |
GO:0031124 | mRNA 3'-end processing | 3.16e-02 | 1.00e+00 | 4.964 | 1 | 2 | 42 |
GO:0006892 | post-Golgi vesicle-mediated transport | 3.23e-02 | 1.00e+00 | 4.930 | 1 | 2 | 43 |
GO:0051591 | response to cAMP | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 4 | 45 |
GO:0006369 | termination of RNA polymerase II transcription | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 2 | 45 |
GO:0043525 | positive regulation of neuron apoptotic process | 3.45e-02 | 1.00e+00 | 4.833 | 1 | 4 | 46 |
GO:0006355 | regulation of transcription, DNA-templated | 3.57e-02 | 1.00e+00 | 1.980 | 3 | 43 | 997 |
GO:0006986 | response to unfolded protein | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 4 | 50 |
GO:0034976 | response to endoplasmic reticulum stress | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 1 | 51 |
GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 51 |
GO:0006879 | cellular iron ion homeostasis | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 3 | 51 |
GO:0051028 | mRNA transport | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 4 | 52 |
GO:0009611 | response to wounding | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 5 | 52 |
GO:0001725 | stress fiber | 4.12e-02 | 1.00e+00 | 4.575 | 1 | 4 | 55 |
GO:0005758 | mitochondrial intermembrane space | 4.19e-02 | 1.00e+00 | 4.549 | 1 | 1 | 56 |
GO:0005643 | nuclear pore | 4.26e-02 | 1.00e+00 | 4.524 | 1 | 11 | 57 |
GO:0006396 | RNA processing | 4.41e-02 | 1.00e+00 | 4.474 | 1 | 5 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 4.41e-02 | 1.00e+00 | 4.474 | 1 | 6 | 59 |
GO:0008013 | beta-catenin binding | 4.48e-02 | 1.00e+00 | 4.450 | 1 | 9 | 60 |
GO:0006406 | mRNA export from nucleus | 4.56e-02 | 1.00e+00 | 4.426 | 1 | 4 | 61 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 4.56e-02 | 1.00e+00 | 4.426 | 1 | 2 | 61 |
GO:0019903 | protein phosphatase binding | 4.63e-02 | 1.00e+00 | 4.402 | 1 | 2 | 62 |
GO:0032869 | cellular response to insulin stimulus | 4.70e-02 | 1.00e+00 | 4.379 | 1 | 1 | 63 |
GO:0009749 | response to glucose | 4.78e-02 | 1.00e+00 | 4.357 | 1 | 7 | 64 |
GO:0010468 | regulation of gene expression | 5.07e-02 | 1.00e+00 | 4.269 | 1 | 2 | 68 |
GO:0034329 | cell junction assembly | 5.07e-02 | 1.00e+00 | 4.269 | 1 | 3 | 68 |
GO:0003697 | single-stranded DNA binding | 5.07e-02 | 1.00e+00 | 4.269 | 1 | 5 | 68 |
GO:0051897 | positive regulation of protein kinase B signaling | 5.21e-02 | 1.00e+00 | 4.227 | 1 | 2 | 70 |
GO:0007584 | response to nutrient | 5.29e-02 | 1.00e+00 | 4.207 | 1 | 3 | 71 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 4 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 5.58e-02 | 1.00e+00 | 4.128 | 1 | 1 | 75 |
GO:0031175 | neuron projection development | 5.58e-02 | 1.00e+00 | 4.128 | 1 | 1 | 75 |
GO:0005929 | cilium | 5.72e-02 | 1.00e+00 | 4.090 | 1 | 2 | 77 |
GO:0071013 | catalytic step 2 spliceosome | 5.79e-02 | 1.00e+00 | 4.071 | 1 | 7 | 78 |
GO:0007229 | integrin-mediated signaling pathway | 5.79e-02 | 1.00e+00 | 4.071 | 1 | 3 | 78 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 5.86e-02 | 1.00e+00 | 4.053 | 1 | 2 | 79 |
GO:0003677 | DNA binding | 5.93e-02 | 1.00e+00 | 1.691 | 3 | 49 | 1218 |
GO:0009653 | anatomical structure morphogenesis | 6.15e-02 | 1.00e+00 | 3.982 | 1 | 2 | 83 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 6.37e-02 | 1.00e+00 | 3.930 | 1 | 8 | 86 |
GO:0006936 | muscle contraction | 6.44e-02 | 1.00e+00 | 3.914 | 1 | 3 | 87 |
GO:0016310 | phosphorylation | 6.66e-02 | 1.00e+00 | 3.865 | 1 | 2 | 90 |
GO:0000187 | activation of MAPK activity | 6.66e-02 | 1.00e+00 | 3.865 | 1 | 3 | 90 |
GO:0007010 | cytoskeleton organization | 6.73e-02 | 1.00e+00 | 3.849 | 1 | 4 | 91 |
GO:0006928 | cellular component movement | 6.73e-02 | 1.00e+00 | 3.849 | 1 | 3 | 91 |
GO:0005770 | late endosome | 6.87e-02 | 1.00e+00 | 3.817 | 1 | 2 | 93 |
GO:0006112 | energy reserve metabolic process | 7.01e-02 | 1.00e+00 | 3.787 | 1 | 2 | 95 |
GO:0005178 | integrin binding | 7.09e-02 | 1.00e+00 | 3.772 | 1 | 4 | 96 |
GO:0008360 | regulation of cell shape | 7.58e-02 | 1.00e+00 | 3.670 | 1 | 4 | 103 |
GO:0031410 | cytoplasmic vesicle | 7.58e-02 | 1.00e+00 | 3.670 | 1 | 4 | 103 |
GO:0005938 | cell cortex | 7.65e-02 | 1.00e+00 | 3.656 | 1 | 5 | 104 |
GO:0005506 | iron ion binding | 7.73e-02 | 1.00e+00 | 3.642 | 1 | 3 | 105 |
GO:0016023 | cytoplasmic membrane-bounded vesicle | 7.73e-02 | 1.00e+00 | 3.642 | 1 | 8 | 105 |
GO:0005741 | mitochondrial outer membrane | 7.73e-02 | 1.00e+00 | 3.642 | 1 | 1 | 105 |
GO:0006006 | glucose metabolic process | 8.64e-02 | 1.00e+00 | 3.474 | 1 | 5 | 118 |
GO:0007050 | cell cycle arrest | 9.06e-02 | 1.00e+00 | 3.402 | 1 | 5 | 124 |
GO:0030027 | lamellipodium | 9.13e-02 | 1.00e+00 | 3.391 | 1 | 7 | 125 |
GO:0030335 | positive regulation of cell migration | 9.27e-02 | 1.00e+00 | 3.368 | 1 | 5 | 127 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 9.34e-02 | 1.00e+00 | 3.357 | 1 | 11 | 128 |
GO:0070062 | extracellular vesicular exosome | 9.50e-02 | 1.00e+00 | 1.128 | 4 | 57 | 2400 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 9.62e-02 | 1.00e+00 | 3.312 | 1 | 4 | 132 |
GO:0016055 | Wnt signaling pathway | 1.00e-01 | 1.00e+00 | 3.248 | 1 | 4 | 138 |
GO:0061024 | membrane organization | 1.05e-01 | 1.00e+00 | 3.177 | 1 | 4 | 145 |
GO:0010628 | positive regulation of gene expression | 1.06e-01 | 1.00e+00 | 3.167 | 1 | 7 | 146 |
GO:0001666 | response to hypoxia | 1.08e-01 | 1.00e+00 | 3.137 | 1 | 7 | 149 |
GO:0031012 | extracellular matrix | 1.11e-01 | 1.00e+00 | 3.090 | 1 | 6 | 154 |
GO:0005578 | proteinaceous extracellular matrix | 1.16e-01 | 1.00e+00 | 3.035 | 1 | 4 | 160 |
GO:0000287 | magnesium ion binding | 1.18e-01 | 1.00e+00 | 2.999 | 1 | 4 | 164 |
GO:0016607 | nuclear speck | 1.24e-01 | 1.00e+00 | 2.930 | 1 | 12 | 172 |
GO:0005667 | transcription factor complex | 1.26e-01 | 1.00e+00 | 2.905 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 1.28e-01 | 1.00e+00 | 2.881 | 1 | 5 | 178 |
GO:0016020 | membrane | 1.28e-01 | 1.00e+00 | 1.227 | 3 | 46 | 1681 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.32e-01 | 1.00e+00 | 2.833 | 1 | 22 | 184 |
GO:0005737 | cytoplasm | 1.33e-01 | 1.00e+00 | 0.799 | 5 | 124 | 3767 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.35e-01 | 1.00e+00 | 2.794 | 1 | 5 | 189 |
GO:0003713 | transcription coactivator activity | 1.67e-01 | 1.00e+00 | 2.468 | 1 | 24 | 237 |
GO:0005975 | carbohydrate metabolic process | 1.77e-01 | 1.00e+00 | 2.374 | 1 | 8 | 253 |
GO:0000166 | nucleotide binding | 1.81e-01 | 1.00e+00 | 2.340 | 1 | 13 | 259 |
GO:0005743 | mitochondrial inner membrane | 1.92e-01 | 1.00e+00 | 2.243 | 1 | 6 | 277 |
GO:0005856 | cytoskeleton | 2.01e-01 | 1.00e+00 | 2.172 | 1 | 9 | 291 |
GO:0015031 | protein transport | 2.31e-01 | 1.00e+00 | 1.943 | 1 | 11 | 341 |
GO:0005925 | focal adhesion | 2.46e-01 | 1.00e+00 | 1.841 | 1 | 9 | 366 |
GO:0007155 | cell adhesion | 2.48e-01 | 1.00e+00 | 1.829 | 1 | 5 | 369 |
GO:0046982 | protein heterodimerization activity | 2.55e-01 | 1.00e+00 | 1.787 | 1 | 8 | 380 |
GO:0005524 | ATP binding | 2.60e-01 | 1.00e+00 | 1.015 | 2 | 31 | 1298 |
GO:0009986 | cell surface | 2.67e-01 | 1.00e+00 | 1.706 | 1 | 9 | 402 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.74e-01 | 1.00e+00 | 1.667 | 1 | 24 | 413 |
GO:0055085 | transmembrane transport | 2.86e-01 | 1.00e+00 | 1.592 | 1 | 8 | 435 |
GO:0044267 | cellular protein metabolic process | 3.08e-01 | 1.00e+00 | 1.468 | 1 | 20 | 474 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.10e-01 | 1.00e+00 | 1.456 | 1 | 24 | 478 |
GO:0042802 | identical protein binding | 3.13e-01 | 1.00e+00 | 1.438 | 1 | 19 | 484 |
GO:0048471 | perinuclear region of cytoplasm | 3.23e-01 | 1.00e+00 | 1.385 | 1 | 8 | 502 |
GO:0005783 | endoplasmic reticulum | 3.51e-01 | 1.00e+00 | 1.238 | 1 | 13 | 556 |
GO:0005730 | nucleolus | 3.61e-01 | 1.00e+00 | 0.676 | 2 | 66 | 1641 |
GO:0005794 | Golgi apparatus | 3.78e-01 | 1.00e+00 | 1.104 | 1 | 9 | 610 |
GO:0007165 | signal transduction | 5.11e-01 | 1.00e+00 | 0.532 | 1 | 13 | 907 |
GO:0005615 | extracellular space | 5.30e-01 | 1.00e+00 | 0.454 | 1 | 20 | 957 |
GO:0008270 | zinc ion binding | 5.45e-01 | 1.00e+00 | 0.395 | 1 | 27 | 997 |
GO:0044281 | small molecule metabolic process | 6.19e-01 | 1.00e+00 | 0.115 | 1 | 20 | 1211 |
GO:0005886 | plasma membrane | 8.86e-01 | 1.00e+00 | -0.978 | 1 | 49 | 2582 |